Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from sprout, a randomized controlled trial

Approved systemic treatment options are limited for pediatric patients with moderate to severe plaque psoriasis.

Source: Journal of the American Academy of Dermatology - January 22, 2024 Category: Dermatology Authors: Loretta Fiorillo, Emily Becker, Raul de Lucas, Anna Belloni-Fortina, Susana Armesto, Boni Elewski, Peter Maes, Rajneet K. Oberoi, Maria Paris, Wendy Zhang, Zuoshun Zhang, Lisa Arkin Source Type: research